We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Sloning Biotechnology and Microsynth Announce Exclusive Distribution Partnership for Switzerland

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Sloning Biotechnology has announced a distribution partnership with Microsynth, a provider of custom oligonucleotide synthesis and DNA sequencing to the Swiss market.

Microsynth will exclusively market and sell Sloning's gene synthesis service (Slonomics™) and the product family of mutant libraries (Slonomax™) in Switzerland.

“We are very pleased that Microsynth will join our global network of qualified distributors. With its strong technological expertise, market position and service philosophy Microsynth is the ideal partner for Sloning to develop the Swiss market,” stated Thomas Matthes, the company CBO.

Dr. Tobias Schmidheini, founder and CEO of Microsynth said, “Sloning´s products and services perfectly complement our portfolio. It’s a strategic development for our organization. We are looking forward to offering Sloning´s products to our customer base.”